Moving closer to a cancer-free world

A message from the president of Greenwich Hospital

The steady decline in smoking – along with advances in early detection and treatment – have led to a 27 percent drop in the U.S. cancer death rate in the past 25 years, reports the American Cancer Society.

At Smilow Cancer Hospital’s Greenwich Hospital Campus, lung cancer patients receive individualized treatment options, including minimally invasive surgery, radiation therapy, chemotherapy and immunotherapy. Yale Medicine experts provide the care, giving area residents access to advanced oncology services from a world-renowned academic medical center.

Still, many challenges remain. Lung cancer accounts for one-quarter of all cancer deaths. And while fewer men have lung cancer than in previous years, more women are being diagnosed with the disease. The growing interest in vaping also threatens to create a new generation addicted to nicotine.

With these challenges, though, comes hope. One of the most exciting developments in the fight against cancer lies in the field of genomics, which aims to understand our genetic information.

As Connecticut’s leading comprehensive cancer center, Smilow Cancer Hospital is at the forefront of genomics research, with the goal of translating this knowledge into new drugs and novel therapeutic strategies and diagnostic tests. Recent news of the world’s first genetic sequencing of precancerous lung lesions will enable researchers to differentiate between lesions that are harmless and those likely to become cancerous.

As evidence that cancer survivors are thriving, please join us at our annual celebration of survivorship on June 6. This joyous event brings together former patients, volunteers and oncology staff. We invite you to enjoy the camaraderie and discover the many reasons to remain hopeful as we move closer to a cancer-free world.

Norman G. Roth, President and Chief Executive Officer